title: Heterogeneity of nephritic factor and its identification as an immunoglobulin.
abstract: Complement C3 nephritic factor (NeF) produces alternative pathway-meciated C3 cleavage by binding to and stabilizing the alternative pathway C3 convertase, C3bBb. Some studies have suggested that NeF is an immunoglobulin, while others conclude that it is a distinct serum protein. The heterogeneity of NeF was evaluated by electrophoresis and isoelectric focusing of NeF-containing serum followed by hemolytic demonstration of NeF activity in agar gel. With each method, diffuse cathodal zones or multiple bands of hemolysis developed, which revealed remarkable variations in patterns from patient to patient. NeF activity was absorbed by and eluted from insolubilized antibody to Fc and Fab fragments of IgG. Immunoabsorption of six NeF-containing sera with insolubilized anti-kappa and anti-lambda light chain antisera revealed that NeF had kappa antigenic determinants in three, lambda antigenic determinants in one, and both kappa and lambda antigenic determinants in two. These data indicate that NeF is an oligoclonal immunoglobulin. Because NeF binds to the alternative pathway C3 convertase, C3bBb, we suggest that it is an antibody to a conformational antigen of the C3-factor B complex, and thereby stabilizes this complex.
mesh_terms: D003176:Complement C3 / Q000172:deficiency; D003178:Complement C3 Nephritic Factor; D003169:Complement Inactivator Proteins; D006801:Humans; D007118:Immunoassay; D007136:Immunoglobulins; D007525:Isoelectric Focusing; D008180:Lupus Erythematosus, Systemic / Q000276:immunology
chemical_list: D003176:Complement C3; D003178:Complement C3 Nephritic Factor; D003169:Complement Inactivator Proteins; D007136:Immunoglobulins
references.citation: Anal Biochem. 1965 Feb;10:358-61
references.pmid: 14302464
references.citation: N Engl J Med. 1965 Sep 2;273:524-9
references.pmid: 14324514
references.citation: J Exp Med. 1965 Aug 1;122:277-98
references.pmid: 14316946
references.citation: Kidney Int. 1976 Oct;10(4):311-8
references.pmid: 62864
references.citation: J Exp Med. 1976 Oct 1;144(4):1062-75
references.pmid: 62010
references.citation: Scand J Immunol. 1976;5(6-7):705-13
references.pmid: 62386
references.citation: N Engl J Med. 1977 Jul 21;297(3):144-5
references.pmid: 865586
references.citation: Clin Immunol Immunopathol. 1977 Mar;7(2):281-7
references.pmid: 862255
references.citation: Lancet. 1972 Dec 2;2(7788):1179-81
references.pmid: 4117597
references.citation: Nature. 1968 Jul 6;219(5149):66-7
references.pmid: 4173351
references.citation: J Biol Chem. 1967 Apr 10;242(7):1651-9
references.pmid: 4164594
references.citation: Science. 1969 Apr 25;164(3878):436-7
references.pmid: 4180576
references.citation: J Exp Med. 1974 May 1;139(5):1249-61
references.pmid: 4207623
references.citation: Adv Nephrol Necker Hosp. 1974;4:91-108
references.pmid: 4220002
references.citation: Immunology. 1972 Jan;22(1):147-58
references.pmid: 4622449
references.citation: N Engl J Med. 1973 Mar 22;288(12):601-6
references.pmid: 4686987
references.citation: J Clin Invest. 1973 Apr;52(4):896-904
references.pmid: 4693654
references.citation: J Immunol. 1976 Mar;116(3):821-6
references.pmid: 815434
references.citation: Immunochemistry. 1976 Apr;13(4):317-24
references.pmid: 820630
references.citation: Clin Exp Immunol. 1976 Jun;24(3):474-82
references.pmid: 939051
references.citation: N Engl J Med. 1976 Feb 26;294(9):461-5
references.pmid: 1246331
references.citation: J Immunol. 1976 Jan;116(1):1-7
references.pmid: 1245733
references.citation: J Exp Med. 1975 Sep 1;142(3):760-72
references.pmid: 1165475
references.citation: Biochim Biophys Acta. 1970 Dec 22;221(3):529-35
references.pmid: 5499437